Technical Analysis for TYME - Tyme Technologies, Inc.

Grade Last Price % Change Price Change
grade F 2.98 0.00% 0.00
TYME closed unchanged on Thursday, July 19, 2018, on 40 percent of normal volume. The stock exhibited some range contraction during this trading session as price made an NR7 -- narrowest range of the last seven sessions.

Trend Table & Recent Alerts
ADX Long-Term Intermediate-Term Short-Term
Weak or Absent Down Down Flat
See historical TYME trend table...

Date Alert Name Type % Chg
Jul 19 Non-ADX 1,2,3,4 Bearish Bearish Swing Setup 0.00%
Jul 19 Narrow Range Bar Range Contraction 0.00%
Jul 19 NR7 Range Contraction 0.00%
Jul 19 Inside Day Range Contraction 0.00%
Jul 19 Wide Bands Range Expansion 0.00%
Jul 18 Outside Day Range Expansion 0.00%
Jul 18 Wide Bands Range Expansion 0.00%
Jul 17 Narrow Range Bar Range Contraction 3.47%
Jul 17 NR7 Range Contraction 3.47%
Jul 17 Inside Day Range Contraction 3.47%

Older signals for TYME ...

Get a Trading Assistant

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
Configure default chart indicators
Basic chart:

Profile
Tyme Technologies, Inc., formerly Global Group Enterprises Corp., conducts majority of its research and development activities and other business operations, through its subsidiary, Tyme Inc. (Tyme). Tyme is a clinical-stage biopharmaceutical company. Tyme is focused on the development and commercialization of highly targeted cancer therapeutics with a range of oncology indications. The Company's another subsidiary, Luminant Biosciences, LLC, conducts the initial research and development of the Company's therapeutic platform. The Company is formulating its regulatory and drug development program for its lead drug candidate, SM-88, and working towards the initiation of its Phase II clinical trial. The Company is also evaluating the expansion of its Phase II program to other types of cancer. The Company has not generated any revenue.
Is TYME a Buy, Sell or Hold?
Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength
Summary: Counts: 0 bullish, 3 bearish and 2 neutral indicators. You may wish to incorporate that into your trading strategies.
Indicators
Indicator Value
52 Week High 9.5
52 Week Low 2.01
Average Volume 416,946
200-Day Moving Average 3.7298
50-Day Moving Average 3.2485
20-Day Moving Average 3.2655
10-Day Moving Average 2.971
Average True Range 0.2815
ADX 20.78
+DI 20.0491
-DI 19.8392
Chandelier Exit (Long, 3 ATRs ) 3.5055
Chandelier Exit (Short, 3 ATRs ) 3.5145
Upper Bollinger Band 3.9621
Lower Bollinger Band 2.5689
Percent B (%b) 0.3
BandWidth 42.664217
MACD Line -0.1125
MACD Signal Line -0.0659
MACD Histogram -0.0466
Fundamentals Value
Market Cap 266.18 Million
Num Shares 89.3 Million
EPS -0.14
Price-to-Earnings (P/E) Ratio -21.29
Price-to-Sales 0.00
Price-to-Book 0.00
PEG Ratio 0.00
Dividend 0.00
Dividend Yield 0.00%
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 3.15
Resistance 3 (R3) 3.14 3.07 3.12
Resistance 2 (R2) 3.07 3.03 3.08 3.11
Resistance 1 (R1) 3.03 3.01 3.00 3.04 3.10
Pivot Point 2.96 2.96 2.95 2.97 2.96
Support 1 (S1) 2.92 2.92 2.89 2.93 2.86
Support 2 (S2) 2.85 2.90 2.86 2.85
Support 3 (S3) 2.81 2.85 2.84
Support 4 (S4) 2.82